Membranous Nephropathy Exclusion Protocol
Corresponding Organization :
Other organizations : Guangzhou University of Chinese Medicine, Guangdong-Hongkong-Macau Joint Laboratory of Collaborative Innovation for Environmental Quality
Variable analysis
- Studies with the following conditions will be excluded: Trials included patients with secondary forms of membranous nephropathy
- Study data could not be available from the report or by contacting the authors
- Patients who were received renal replacement therapy
- Studies assessed
A membranaceus combined with other complementary therapies (such as moxibustion, acupuncture) - Therapies related to TCM were used in the control group
- Western medicine was contained in both groups, but they were differented from each other
- Huangqi doesn't serves as a principal medicine
- Not explicitly mentioned
- Not explicitly mentioned
- No positive or negative controls specified
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!